Register for streaming realtime charts, analysis tools, and prices.

Get Started

RUBY Rubius Therapeutics Inc

0.083

0.00 (0.00%)

Pre Market

Last Updated: 20:00:00

Delayed by 15 minutes

Rubius Therapeutics begins dosing in phase 1/2 trial of RTX-224 for solid tumors

To read the full story on Seeking Alpha, click here.

Rubius Therapeutics (NASDAQ:RUBY)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Rubius Therapeutics Charts.

Rubius Therapeutics (NASDAQ:RUBY)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Rubius Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Rubius Therapeutics Inc News

More Rubius Therapeutics Inc News Articles

Net Savings Link (PK)

Apple Rush (PK)

International Star (PK)

Global Developments (PK)

Enzolytics (PK)

Rennova Health (PK)

FBEC Worldwide (PK)

Kraig Biocraft Laborator... (QB)

Mike The Pike Productions (PK)

Delayed Upgrade Clock